Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 8, 2022Annals of MedicineOpen Access

The mechanism of triptolide in the treatment of connective tissue disease-related interstitial lung disease based on network pharmacology and molecular docking

View Full Paper
Ask AI
Bookmark
Share

Authors

WZWen ZhuJiangsu UniversityYLYehui LiNanjing University of Chinese MedicineJZJunjie ZhaoHangzhou Medical College

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zhu et al. (2022) studied this question.

synapsesocial.com/papers/6a8a90031fb56efa37d4ab69https://doi.org/10.1080/07853890.2022.2034931
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading2009 · 38,941 citations
  2. 2Cytokine profiles, signalling pathways and effects of fluticasone propionate in respiratory syncytial virus‐infected human foetal lung fibroblasts2013 · 13 citations
  3. 3Cellular and molecular mechanisms of fibrosis2007 · 4,570 citations
  4. 4Comparative Toxicogenomics Database: a knowledgebase and discovery tool for chemical-gene-disease networks2008 · 332 citations
  5. 5Viruses as co-factors for the initiation or exacerbation of lung fibrosis2008 · 85 citations